Showing 121 - 140 results of 463 for search '"Atrial fibrillation"', query time: 0.10s Refine Results
  1. 121

    Biomarkers for Predicting Left Atrial or Left Atrial Appendage Thrombus in Anticoagulated Patients with Nonvalvular Atrial Fibrillation by Xue Zhou, Zuolan Wang, Shuang Dou, Kangyin Chen, Enzhao Liu, Tong Liu, Guangping Li, Jingjin Che

    Published 2020-01-01
    “…Purpose. Although atrial fibrillation (AF) is often associated with thromboembolic complications, there is no definite biomarker for detecting the presence of thrombi in the left atrial (LA) or left atrial appendage (LAA) in patients with nonvalvular atrial fibrillation (NVAF). …”
    Get full text
    Article
  2. 122
  3. 123

    Postoperative New-Onset Atrial Fibrillation following Noncardiac Operations: Prevalence, Complication, and Long-Term MACE by Ofir Koren, Rony Hakim, Asaf Israeli, Ehud Rozner, Yoav Turgeman

    Published 2020-01-01
    “…Postoperative new-onset atrial fibrillation (POAF) is a common complication following cardiothoracic surgery, but little is known regarding its occurrence and outcome following noncardiothoracic surgery. …”
    Get full text
    Article
  4. 124

    Screening for Atrial Fibrillation by Digital Health Technology in Older People in Homecare Settings: A Feasibility Trial by Edvard Liljedahl Sandberg, Sigrun Halvorsen, Trygve Berge, Jostein Grimsmo, Dan Atar, Bjørnar Leangen Grenne, Jarle Jortveit

    Published 2024-01-01
    “…Users of homecare services are often excluded from clinical trials due to advanced age, multimorbidity, and frailty. Atrial fibrillation (AF) is a common and frequently undiagnosed arrhythmia in the elderly and is associated with severe mortality, morbidity, and healthcare costs. …”
    Get full text
    Article
  5. 125
  6. 126

    The Study of Cost-Effectiveness of Rivaroxaban versus Warfarin in Patients with Atrial Fibrillation Who Developed Ischemic Stroke by Neda Jaberi, Zahra Kavosi, Etrat Hooshmandi, Nasrin Moradi, Khosro Keshavarz, Afshin Borhani-Haghighi

    Published 2021-01-01
    “…Rivaroxaban is a new anticoagulant providing benefits for the treatment of patients with atrial fibrillation (AF). This study is aimed at evaluating the cost-effectiveness of rivaroxaban compared to warfarin in patients with AF. …”
    Get full text
    Article
  7. 127

    Double Transseptal Puncture for Catheter Ablation of Atrial Fibrillation: Safety of the Technique and Its Use in the Outpatient Setting by Laurent M. Haegeli, Thomas Wolber, Ercüment Ercin, Lukas Altwegg, Nazmi Krasniqi, Paul G. Novak, Laurence D. Sterns, Corinna B. Brunckhorst, Thomas F. Lüscher, Richard A. Leather, Firat Duru

    Published 2010-01-01
    “…For pulmonary vein isolation in patients with atrial fibrillation (AF), some centers use the double transseptal puncture technique for catheter access in order to facilitate catheter manipulation within the left atrium. …”
    Get full text
    Article
  8. 128

    Continuous atrial fibrillation monitoring using a wearable smartwatch: Using long-term Holter as reference by Yannan Pan, Erdong Chen, Shihui Jie, Dongbo Huo, Zhongru Ding, Jing Zhou, Jie Jiang, Jianping Li, Yong Huo

    Published 2025-01-01
    “…Background Wearables satisfactorily detect atrial fibrillation (AF) longer than 1 hour. Our study aims to evaluate smartwatch performances for long-term AF monitoring, including AF with short durations. …”
    Get full text
    Article
  9. 129
  10. 130

    Association between ZFHX3 and PRRX1 Polymorphisms and Atrial Fibrillation Susceptibility from Meta-Analysis by Liting Wu, Min Chu, Wenfang Zhuang

    Published 2021-01-01
    “…Background. Atrial fibrillation (AF) is a common, sustained cardiac arrhythmia. …”
    Get full text
    Article
  11. 131
  12. 132

    A systematic review on the influence of coagulopathy and immune activation on New Onset Atrial Fibrillation in patients with sepsis. by Brian W Johnston, Michael Downes, Angela Hall, Zachary Thomas, Ingeborg D Welters

    Published 2025-01-01
    “…<h4>Introduction</h4>New Onset Atrial Fibrillation (NOAF) is the most common arrhythmia in intensive care. …”
    Get full text
    Article
  13. 133

    Combined Catheter Ablation and Left Atrial Appendage Closure in Atrial Fibrillation Patients with and without Prior Stroke by Bin-Feng Mo, Rui Zhang, Jia-Li Yuan, Jian Sun, Peng-Pai Zhang, Wei Li, Mu Chen, Qun-Shan Wang, Yi-Gang Li

    Published 2021-01-01
    “…Background. Combined atrial fibrillation (AF) ablation and left atrial appendage closure (LAAC) has been practiced for management of both the symptoms and the high stroke risk of AF. …”
    Get full text
    Article
  14. 134

    Association between Serum Adiponectin and Atrial Fibrillation: A Case-Control Study Stratified by Age and Gender by Tongjian Zhu, Zhuo Wang, Songyun Wang, Wei Hu, Hui Chen, Jing Xie, Meng Wang, Kezhong Ma, Hong Jiang

    Published 2021-01-01
    “…Circulating adiponectin has been suggested to be associated with atrial fibrillation (AF). However, whether the association differs by age and gender remains unknown. …”
    Get full text
    Article
  15. 135

    Digoxin Use to Control Ventricular Rate in Patients with Atrial Fibrillation and Heart Failure Is Not Associated with Increased Mortality by Surbhi Chamaria, Anand M. Desai, Pratap C. Reddy, Brian Olshansky, Paari Dominic

    Published 2015-01-01
    “…Digoxin is used to control ventricular rate in atrial fibrillation (AF). There is conflicting evidence regarding safety of digoxin. …”
    Get full text
    Article
  16. 136

    Effects of Renal Denervation via Renal Artery Adventitial Cryoablation on Atrial Fibrillation and Cardiac Neural Remodeling by Wei Wang, Zhaolei Jiang, Rongxin Lu, Hao Liu, Nan Ma, Jie Cai, Min Tang, Ju Mei

    Published 2018-01-01
    “…Catheter-based renal denervation (RDN) could reduce cardiac sympathetic nerve activity (SNA) and inhibit atrial fibrillation (AF). However, the reliability is uncertain, because the renal sympathetic nerves are mainly distributed in the adventitial surface of the renal artery. …”
    Get full text
    Article
  17. 137

    Early Outcomes With Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation by Shashank Shekhar, MD, Amar Krishnaswamy, MD, Grant Reed, MD, MSc, James Yun, MD, Rishi Puri, MD, PhD, Samir Kapadia, MD

    Published 2025-01-01
    “…We aimed to analyze the impact of CPD use during TAVR among patients with atrial fibrillation (AF). Methods: Data on adult TAVR patients with a concomitant diagnosis of AF was obtained from the 2017-2020 National Readmissions Database. …”
    Get full text
    Article
  18. 138

    ANGPTL4 Attenuates Ang II-Induced Atrial Fibrillation and Fibrosis in Mice via PPAR Pathway by Xi Zhu, Xiaogang Zhang, Xinpeng Cong, Luoning Zhu, Zhongping Ning

    Published 2021-01-01
    “…Atrial fibrillation (AF) is the more significant portion of arrhythmia in clinical practice, with inflammation and fibrosis as its central pathological mechanisms. …”
    Get full text
    Article
  19. 139
  20. 140